Autonomix Medical Secures $4.9M Through Warrant Inducement, Issues 1.07M New Warrants at $6.25
AMIX has more than doubled off its 52-week low of $2.44 on elevated volume (6.4× avg).
Summary
Autonomix Medical raised $4.9M by inducing exercise of existing warrants at $5.75, issuing 1.07M new Series E warrants at $6.25 in return. The capital extends runway but adds future dilution.
Key Events · Financing and Capital Events · AMIX
-
Warrant Inducement Raises $4.9M
Holders exercised 857,462 existing Series D-1/D-2 warrants at $5.75 per share, generating approximately $4.9 million in gross proceeds before fees.
-
1.07M New Warrants Issued
The company issued 535,913 Series E-1 and 535,913 Series E-2 warrants, each exercisable at $6.25 per share with a 5-year term — adding future dilution potential.
-
Financial Advisor Compensation
Maxim Group LLC receives a 7.0% cash fee on total proceeds plus up to $15,000 in expense reimbursement.
-
Equity Issuance Lock-Up
The company is prohibited from issuing new equity until September 13, 2026, and from variable-rate transactions until January 11, 2027.
Analysis · AMIX · Industrial Applications And Services
Autonomix Medical is exercising its existing Series D warrants to raise approximately $4.9 million in gross proceeds, a meaningful capital infusion for a company with a market cap near $7 million and cash runway only into Q1 2027. In exchange, the company is issuing 1,071,826 new Series E warrants at a $6.25 exercise price — above the $5.75 exercise price of the warrants being exercised — which adds future dilution potential. The deal includes a 7% financial advisory fee to Maxim Group and a lock-up on new equity issuances until September 13, 2026, plus a prohibition on variable-rate transactions until January 2027. This is the second warrant inducement in six weeks, following the $2.6M raise in July, and comes as the company faces a new Nasdaq delisting risk from the $5M minimum market value rule.
How filings like this one have moved
In the 30 days to Oct 17, 2026, 29.7% of the 1516 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.48%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AMIX was trading at $6.44 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7M. The 52-week trading range was $2.44 to $32.55. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.